Replies to post #102241 on US Stem Cell Inc (USRM)

[FIREST1]

Pay for clinical trial is the starting point for the FDA to make money on stem cells. Once they realize all the potential pathways to make money, Stem cells will not be the " black sheep / fake actors" that they've been labeled. Lots of hurdles, but I think we will get to a happy place. USRM for the win!!

[TheWhigs]

To me it seems like a "double standard" on the FDA's part.